Oncolytic viruses for cancer immunotherapy

被引：0
|
作者：
Otto Hemminki
João Manuel dos Santos
Akseli Hemminki
机构：
[1] University Health Network and University of Toronto,Division of Urologic Oncology, Department of Surgical Oncology, Princess Margaret Cancer Centre
[2] University of Helsinki,Cancer Gene Therapy Group, Translational Immunology Research Program
[3] Helsinki University Hospital,Department of Urology
[4] TILT Biotherapeutics Ltd,undefined
[5] Helsinki University Hospital Comprehensive Cancer Center,undefined
来源：
Journal of Hematology & Oncology | / 13卷
关键词：
Adenovirus; Oncolytic; Tumor; Cancer; Immunotherapy; Review; Immunology; Immune system; Immunosupression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In this review, we discuss the use of oncolytic viruses in cancer immunotherapy treatments in general, with a particular focus on adenoviruses. These serve as a model to elucidate how versatile viruses are, and how they can be used to complement other cancer therapies to gain optimal patient benefits. Historical reports from over a hundred years suggest treatment efficacy and safety with adenovirus and other oncolytic viruses. This is confirmed in more contemporary patient series and multiple clinical trials. Yet, while the first viruses have already been granted approval from several regulatory authorities, room for improvement remains.
引用
收藏
相关论文
共 50 条
  • [1] Oncolytic viruses for cancer immunotherapy
    Hemminki, Otto
    dos Santos, Joao Manuel
    Hemminki, Akseli
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [2] Oncolytic Viruses in Cancer Immunotherapy
    Li, Xiao
    Cheng, Zhongping
    ADVANCED THERAPEUTICS, 2024, 7 (07)
  • [3] Oncolytic Viruses and Cancer Immunotherapy
    Malhotra, Jyoti
    Kim, Edward S.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (01) : 19 - 28
  • [4] A promising future in cancer immunotherapy: Oncolytic viruses
    Seyed-Khorrami, Seyed-Mahmood
    Azadi, Arezou
    Rastegarvand, Nasrin
    Habibian, Ala
    Soleimanjahi, Hoorieh
    Los, Marek J.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 960
  • [5] Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
    Rahman, Masmudur M.
    McFadden, Grant
    CANCERS, 2021, 13 (21)
  • [6] Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors
    Li, Qingbo
    Oduro, Patrick Kwabena
    Guo, Rui
    Li, Ruiqiao
    Leng, Ling
    Kong, Xianbin
    Wang, Qilong
    Yang, Long
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [7] Oncolytic Viruses and Their Application to Cancer Immunotherapy
    Chiocca, E. Antonio
    Rabkin, Samuel D.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (04) : 295 - 300
  • [8] The discovery and development of oncolytic viruses: are they the future of cancer immunotherapy?
    Zhang, Shunchuan
    Rabkin, Samuel D.
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (04) : 391 - 410
  • [9] Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy
    Omole, Richard Kolade
    Oluwatola, Oluwaseyi
    Akere, Millicent Tambari
    Eniafe, Joseph
    Agboluaje, Elizabeth Oladoyin
    Daramola, Oluwafemi Bamidele
    Ayantunji, Yemisi Juliet
    Omotade, Temiloluwa Ifeoluwa
    Torimiro, Nkem
    Ayilara, Modupe Stella
    Adeyemi, Oluwole Isaac
    Salinsile, Olubusola Sajanat
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] Fusogenic Viruses in Oncolytic Immunotherapy
    Krabbe, Teresa
    Altomonte, Jennifer
    CANCERS, 2018, 10 (07):
12345